FOXO4-DRI
FOXO4-DRI is a D-retro-inverso peptide designed to disrupt the interaction between FOXO4 and p53 in senescent cells, triggering their selective apoptosis. one of the most expensive research peptides on PeptideCompare, and one of the most scientifically interesting in longevity research.
Potency loss over time
Estimated potency retained (%) per storage condition. Hover the chart for details.
⚠ Estimates modelled per compound from its molecular properties (sequence length, cyclisation, oxidation- and deamidation-prone residues, light sensitivity). Indicative only — not lab-measured per batch.
Time in body
| # | Suppliers | Price | €/mg | Price trend (6 months) | Purity | COA | Score ⓘ | |
|---|---|---|---|---|---|---|---|---|
| 1 |
 CRY
| €174.99 | €17.5/mg | 99% | ✔ HPLC | Shop → | ||
| 2 |
 24P
24PEPTIDES
in stock 🇳🇱 NL
| €179 | €17.9/mg | ▼2.6% | 99% | ✔ Liquilabs | Shop → | |
| 3 |
 RES
RESEARCH PEPTIDES EUROPE
in stock 🇪🇸 ES
| €189.99 | €19.0/mg | 99.8% | ✔ HPLC/LC-MS | Shop → | ||
| 4 |
 PAR
PARTICLE PEPTIDES
in stock 🇸🇰 SK
| €214.99 | €21.5/mg | ▼5.3% | 99% | ✔ HPLC/LC-MS | Shop → |
Prices manually checked and updated monthly — source: publicly available supplier data. No affiliate links, no paid placement.
FOXO4-DRI
Mechanism, evidence level, EU status and COA guidance per compound. No dosages, no protocols — that belongs with a doctor.